Riederer, M., Erwa, W., Zimmermann, R., Frank, S
Quality Standards Across All Three All three are Janoshik-verified to 99% purity with mass-spec identity confirmation
FDA black box warning for cardiovascular events and malignancy Baricitinib (Olumiant) oral JAK1/JAK2 inhibitor Upadacitinib (Rinvoq) oral selective JAK1 inhibitor Filgotinib (Jyseleca) selective JAK1 inhibitor (EU-approved) Adjunctive Therapies NSAIDs (naproxen, ibuprofen, celecoxib) symptom relief, not disease-modifying Corticosteroids (prednisone, methylprednisolone) bridge therapy, disease flares, intra-articular injection (CPT 20610/20611) Intra-articular corticosteroid injections corticosteroid local anesthetic
We offer account credits for approved refunds, which never expire and can be used on any Vyora product or service